RUNX1 loss renders hematopoietic and leukemic cells dependent on IL-3 and sensitive to JAK inhibition
Amy C Fan, Y. Nakauchi, Lawrence Bai, Armon Azizi, Kevin A. Nuno, Feifei Zhao, T. Köhnke, Daiki Karigane, D. Cruz-Hernandez, A. Reinisch, P. Khatri, R. Majeti
Journal of Clinical Investigation